The Newton community is coming together looking to save one of its own. Newton High School student Johnna Hulett was recently ...

The study demonstrated a poor prognosis overall for patients with acute myeloid leukemia (AML) who were previously treated ...

A fight to end blood cancer and help Johnna beat it.

Newton High School and the surrounding community will rally around 15-year-old local student Johnna Hulett as she seeks a ...

Lee Greenberger, PhD, has retired as The Leukemia & Lymphoma Society’s chief scientific officer after more than a decade in ...

A Benton County family is making Spokane their temporary home after their 14-year-old was diagnosed with Acute Myeloid ...

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

The investigational drug, called PMD-026, is currently in phase 2 clinical trials for the treatment of breast cancer.

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

Arcellx's anito-cel shows promising efficacy and safety in multiple myeloma. Read why I maintain my hold rating for ACLX ...

Molecular Partners' DARPin platform shows promise, but future funding is uncertain. Learn why MOLN stock could be a risky, ...